http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011088836-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f790dd306af2f09e103b310a6af9ec06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6dec1fe64aca717479b5d4c557ce03de http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14 |
| filingDate | 2011-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4697427f79e050e0b7942c93e011937b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f4f6330f1a1b006911e5b67b33bc67f |
| publicationDate | 2011-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2011088836-A1 |
| titleOfInvention | NOVEL 4-(ARYL-4-SULFONYL)-6,6a,7,8,9,10-HEXAHYDRO-4H-4,8,10a-TRIAZA-ACEPHENANTHRYLENE AND 3-ARYLSULFONYL-6,6a,7,8,9,10-HEXAHYDRO-3H-3,8,10a-TRIAZA-CYCLOPENTA[C]FLUORENE DERIVATIVES AS SEROTONIN 5-HT6 LIGANDS |
| abstract | This invention is directed to compounds of formula I or II, which are serotonin 5-HT 6 ligands. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides processes for the preparation of the compounds of formula I or II, or a pharmaceutically acceptable salt thereof. The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I or II, or a pharmaceutically acceptable salt thereof. The present invention further provides a method of treating a subject suffering from a psychiatric disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I or II, or a pharmaceutically acceptable salt thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114835709-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023036177-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015286049-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114835709-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022161493-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016004882-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9974785-B2 |
| priorityDate | 2010-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 610.